Export Solutions

Export

CigoLab provides commercial and strategic support to enable the global market entry of products it develops or undertakes to develop.

Target Market Analysis

Product-specific market potential assessment
Reimbursement system analysis
Competitive landscape evaluation
Country-specific requirements for regulatory documentation

Export Strategy Development

Country selection
Product launch planning
Global pricing strategy
Establishment of commercial distributor networks

Regulatory & Licensing

CTD dossier preparation
GMP/GDP compliance assessment
Country-specific technical dossier preparation

International Partner Management

Distributor identification
Manufacturer sourcing
Contract structuring and commercialization models

Detail Project

Client

BioNova Therapeutics

Project Start Date

March 12, 2024

Location

Cambridge, Massachusetts

Book an Appointment

Desciription

Nulla magnis nibh lectus posuere fames hendrerit elit faucibus quisque accumsan ultrices. Hendrerit sollicitudin taciti cursus pede est mollis aliquet facilisi mi. Penatibus accumsan augue taciti faucibus odio mauris id est elementum natoque nascetur. Elit luctus posuere ad eros interdum convallis sem nunc sit.

Tempus bibendum risus cubilia non elementum morbi mi iaculis hac. Quisque nec facilisis purus arcu facilisi molestie est torquent blandit. Habitant vestibulum natoque quisque imperdiet ligula. Mattis duis auctor enim curae phasellus habitasse.

Play Intro

Research Outcomes

Consectetuer tellus cursus magna efficitur congue etiam maximus pharetra taciti ut. Senectus consectetuer placerat fames letius pellentesque vestibulum purus nisi est in conubia. Dis auctor turpis diam non nam a augue efficitur inceptos vehicula fames. Ullamcorper justo ligula tincidunt fusce turpis.

Developed gold-based nanoparticles for targeted cancer therapy.
Achieved 35% increase in drug absorption efficiency.
Created nanocoating prototypes for sustained medicine release.
Published results in the Journal of Nanomedicine and Biotechnology (2025).
Supported ongoing clinical trials in partnership with BioNova Therapeutics.

Play Intro

Explore How Syntalab Transforms Research Into Results